Rausch, J., Dzama, M. M., Dolgikh, N., Stiller, H. L., Bohl, S. R., Lahrmann, C., Kunz, K., Kessler, L., Echchannaoui, H., Chen, C.-W., Kindler, T., Döhner, K., Burrows, F., Theobald, M., Sasca, D. and Kühn, M. W. (2023) “Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with <i>MLL</i> rearrangement or <i>NPM1</i&gt; mutation to venetoclax”, Haematologica. Pavia, Italy, 108(10), pp. 2837-2843. doi: 10.3324/haematol.2022.282160.